• Find an Expert
  • Search iconSearch
  • Menu
  • Help
  • Report an issue

Official Order for Stage 2 and Stage 3 of the Review of cost effectiveness of Type 2 Diabetes medicines

| Funding period: 2021 - 2022

Completed

Related publications (2)

Scholarly works icon

Clinical and cost utility evaluation of glucagon-like peptide 1 analogues for the treatment of type 2 diabetes in the Australian setting

An Tran-Duy, Tessa Peasgood, Patrick Abraham, Philip Clarke

2021-12-14

Scholarly works icon

Clinical and cost-utility evaluation of sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes in the Australian setting

An Tran-Duy, Andrew Palmer, Philip Clarke

2021-11-26

University of Melbourne Researchers

An Duy Tran's Profile Picture
An Duy Tran Melbourne School of Population and Global Health

Philip Clarke's Profile Picture
Philip Clarke Melbourne School of Population and Global Health

Tessa Peasgood's Profile Picture
Tessa Peasgood

Patrick Abraham's Profile Picture
Patrick Abraham Melbourne School of Population and Global Health

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  ›

About us  

›

Careers at Melbourne  

›

Safety and respect  

›

Newsroom  

›

Contact  

›

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  ›
facebookIcontwitterIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224